Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Impedimed

1999 FOUNDED
PUBLIC STATUS
61-70 EMPLOYEES
IPD STOCK SYMBOL
2 INVESTMENTS
$0.09 SHARE PRICE (As of Tuesday Closing)
Description

Impedimed Ltd is a medical devices company. The company has two business segments: Medical and Test and Measurement. The Medical segment is engaged in the development, manufacture, and sale of noninvasive medical devices. These products are typically utilized for individuals with lymphedema and monitoring hydration. These include L-Dex U400 and SFB7. The company generates the vast majority of its revenue in Australia.

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Medical Supplies
Other Industries
Monitoring Equipment
Stock Exchange
ASX
Primary Office
  • Unit 1
  • 50 Parker Court
  • Pinkenba, Queensland 4008
  • Australia

+61 (07) 0000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Impedimed’s full profile, request a free trial.

Impedimed Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.07 - $0.40 $33.7M $0.09 1.4M 383M

Impedimed Financials Summary

In Thousands,
USD
TTM
30-Jun-2019
FY 2019
30-Jun-2019
FY 2018
30-Jun-2018
FY 2017
30-Jun-2017
Enterprise Value 14,578 14,578 76,629 175,697
Revenue 4,345
EBITDA (21,011)
Net Income (20,777)
Total Assets 30,682 49,444
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Impedimed Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Impedimed‘s full profile, request access.

Request full access to PitchBook

Impedimed Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000000 00000 26-Oct-2015 000000000000000000 Surgical Devices 0000000 0000000
XiTRON Technologies 01-Oct-2007 Merger/Acquisition Electronic Equipment and Instruments 0000000 00000
To view this company’s complete investment and acquisition history, request access »

Impedimed Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000 00000000000 01-Oct-2007 000000000000000000 Completed
  • 000000000
To view this company’s complete exits history, request access »

Impedimed Executive Team (5)

Name Title Board
Seat
Contact
Info
Richard Carreon President, Managing Director & Chief Executive Officer
Phil Auckland Chief Financial Officer & Chief Operating Officer
Morten Vigeland Chief Financial Officer
Chris Bulger Director, Business Development

1 Former Executive

You’re viewing 4 of 5 executives. Get the full list »

Impedimed Board Members (2)

Name Representing Role Since Contact
Info
Cherrell Hirst Impedimed Chairman 000 0000

1 Former Board Member

You’re viewing 1 of 2 board members. Get the full list »